SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049072
Filing Date
2024-04-26
Accepted
2024-04-26 16:02:26
Documents
8
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A cue-def14a-2024_proxy.htm DEF 14A 959877
2 GRAPHIC img88781609_0.jpg GRAPHIC 31500
3 GRAPHIC img88781609_1.jpg GRAPHIC 31500
4 GRAPHIC img88781609_2.jpg GRAPHIC 31500
5 GRAPHIC img88781609_3.jpg GRAPHIC 34490
6 GRAPHIC img88781609_4.jpg GRAPHIC 37751
7 GRAPHIC img88781609_5.jpg GRAPHIC 106435
8 GRAPHIC img88781609_6.jpg GRAPHIC 72876
  Complete submission text file 0000950170-24-049072.txt   1438185
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38327 | Film No.: 24883427
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)